Adult Peritoneal Dialysis-Related Peritonitis Treatment Recommendations: 2000 Update

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Peritoneal Dialysis International

• Publication date

  2000-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/089686080002000406PMID 11007371
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antibiogram Development for an Outpatient Dialysis Center

  2000cited by this paper
• Pharmacokinetics of intermittent intravenous cefazolin and tobramycin in patients treated with automated peritoneal dialysis.

  2000cited by this paper
• The rise in bacterial resistance

  2000cited by this paper
• Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.

  1999cited by this paper
• Pharmacokinetics of Intermittent Intraperitoneal Cefazolin in Continuous Ambulatory Peritoneal Dialysis Patients

  1999cited by this paper
• Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients.

  1999cited by this paper
• Peritonitis in patients on automated peritoneal dialysis.

  1999cited by this paper
• Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment.

  1999cited by this paper
• Once Daily Aminoglycoside Therapy

  1999cited by this paper
• Simultaneous catheter removal and replacement in peritoneal dialysis infections: update and current recommendations.

  1999cited by this paper
• Pharmacokinetics of intermittent intraperitoneal ceftazidime.

  1999cited by this paper
• Once-daily intraperitoneal cefazolin and oral ciprofloxacin as empiric therapy for the treatment of peritonitis.

  1999cited by this paper
• Once-Daily Intraperitoneal Gentamicin is Effective Therapy for Gram-Negative Capd Peritonitis

  1999cited by this paper
• Simultaneous catheter removal and replacement in peritoneal dialysis infections: update and current recommendations.

  1999cited by this paper
• New strategies to prevent Staphylococcus aureus infections in peritoneal dialysis patients.

  1998cited by this paper
• The Need for a Center Tailored Treatment Protocol for Peritonitis

  1998cited by this paper
• Intermittent intraperitoneal ceftazidime dosing in end-stage renal disease.

  1998cited by this paper
• Improved detection of bacterial growth in continuous ambulatory peritoneal dialysis effluent by use of BacT/Alert FAN bottles

  1997cited by this paper
• Treatment in Pd Patients of Peritonitis Caused by Gram-Positive Organisms with Single Daily Dose of Antibiotics

  1997cited by this paper
• Failure to cure Mycobacterium gordonae peritonitis associated with continuous ambulatory peritoneal dialysis.

  1997cited by this paper
• Impaired Initial Cell Reaction in Capd-Related Peritonitis

  1996cited by this paper
• Single or multiple daily doses of aminoglycosides: a meta- analysis

  1996cited by this paper
• Peritonitis associated with exit site and tunnel infections.

  1996cited by this paper
• Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. Mupirocin Study Group.

  1996cited by this paper
• A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin.

  1996cited by this paper
• Pharmacokinetics of Once-Daily Ip Gentamicin in Capd Patients

  1996cited by this paper
• Optimal treatment and long-term outcome of tuberculous peritonitis complicating continuous ambulatory peritoneal dialysis.

  1996cited by this paper
• Absorption Interactions With Fluoroquinolones

  1995cited by this paper
• Treatment of recurrent and resistant CAPD peritonitis by temporary withdrawal of peritoneal dialysis without removal of the catheter.

  1995cited by this paper
• Pharmacokinetic issues in the treatment of continuous ambulatory peritoneal dialysis-associated peritonitis.

  1995cited by this paper
• Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC).

  1995cited by this paper
• Treatment of resistant peritonitis in continuous ambulatory peritoneal dialysis with intraperitoneal urokinase: a double-blind clinical trial.

  1994cited by this paper
• Renaissance of tuberculosis in the 1990s: lessons for the nephrologist.

  1994cited by this paper
• Renaissance of Tuberculosis in the 19905: Lessons for the Nephrologist

  1994cited by this paper
• Continuous Ambulatory Peritoneal Dialysis Catheter Infections: Diagnosis and Management

  1994cited by this paper
• Nontuberculous mycobacterial infections in continuous ambulatory peritoneal dialysis patients.

  1993cited by this paper
• Pharmacokinetics of Intravenous and Intraperitoneal Ceftazidime in Chronic Ambulatory Peritoneal Dialysis

  1993cited by this paper
• Antimicrobial Treatment of Peritonitis Associated with Continuous Ambulatory Peritoneal Dialysis

  1991cited by this paper
• Once-daily aminoglycoside therapy

  1991cited by this paper
• Simultaneous catheter replacement and removal in refractory peritoneal dialysis infections.

  1991cited by this paper
• Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections.

  1991cited by this paper
• Comparison of Large Volume Culture to Other Methods for Isolation of Microorganisms from Dialysate

  1990cited by this paper
• Exit-site care and exit-site infection in continuous ambulatory peritoneal dialysis (CAPD): results of a randomized multicenter trial.

  1990cited by this paper
• Aminoglycoside-induced ototoxicity.

  1990cited by this paper
• Tenckhoff Catheter Replacement or Intraperitoneal Urokinase: A Randomised Trial in the Management of Recurrent Continuous Ambulatory Peritoneal Dialysis (CAPD) Peritonitis

  1989cited by this paper
• Fungal peritonitis complicating peritoneal dialysis: report of 27 cases and review of treatment.

  1989cited by this paper
• Pseudomonas peritonitis in CAPD patients: characteristics and outcome of treatment.

  1989cited by this paper
• Peritonitis in Continuous Ambulatory Peritoneal Dialysis {CAPD): A Multi-Centre Randomized Clinical Trial Comparing the Y Connector Disinfectant System to Standard Systems

  1989cited by this paper
• Randomized trials of aminoglycoside antibiotics: quantitative overview.

  1988cited by this paper
• Peritonitis during Continuous Ambulatory Peritoneal Dialysis (CAPD): Risk Factors, Clinical Severity, and Pathogenetic Aspects

  1988cited by this paper
• Six Years’ Experience of CAPD at One Centre: A Survey of Major Findings

  1988cited by this paper
• Withdrawal of continuous ambulatory peritoneal dialysis to treat mild peritonitis.

  1988cited by this paper

• Dialyse péritonéale chez l'enfant : Approches physiopathologiques, prescription et gestion des complications pour un traitement adéquat.

  2025cites this paper
• Peritoneal dialysis related eosinophilic peritonitis: a case report and review of the literature

  2023cites this paper
• Phenotypic and Molecular Characterization of Nonfermenting Gram-Negative Bacilli Causing Peritonitis in Peritoneal Dialysis Patients

  2022cites this paper
• A case of Moesziomyces antarcticus peritonitis in a patient undergoing peritoneal dialysis

  2022cites this paper
• ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment

  2022influential citation
• Brevundimonas vesicularis Peritonitis in a Chronic Peritoneal Dialysis Patient

  2021cites this paper
• Infectious Complications of Peritoneal Dialysis in Children

  2021cites this paper
• Lessons learnt and future directions in managing dialysis access during the COVID 19 pandemic: Patient and provider experience in the United States

  2021cites this paper
• Peritoneal Dialysis in Children

  2021cites this paper
• Mycobacterium tuberculosis peritonitis in peritoneal dialysis patients: A scoping review

  2021cites this paper
• Peritoneal Infections in Peritoneal Dialysis (PD Peritonitis)

  2021cites this paper
• The impact of intraperitoneal antibiotic administration in patients with peritoneal dialysis-related peritonitis: systematic review and meta-analysis

  2020cites this paper
• Ten-year survival of patients treated with peritoneal dialysis: A prospective observational cohort study

  2020cites this paper
• Prescribing high-quality peritoneal dialysis: The role of preserving residual kidney function

  2020cites this paper
• Measurement of innate immune response biomarkers in peritoneal dialysis effluent using a rapid diagnostic point-of-care device as a diagnostic indicator of peritonitis.

  2020cites this paper
• Predictors of peritoneal dialysis associated peritonitis; application of the zero-inflated negative binomial model

  2019cites this paper
• Effects of prophylactic antibiotics before peritoneal dialysis catheter implantation on the clinical outcomes of peritoneal dialysis patients

  2019influential citation
• Concerns Regarding Inconsistencies Within and Between ISPD Recommendations for Peritonitis and Catheter-Related Infections—In Reply

  2018cites this paper
• Fungal peritonitis in continuous ambulatory peritoneal dialysis patients; a study from South of India

  2018cites this paper
• Microbiological profile of peritoneal dialysis fluid in acute and chronic renal failure patients in a tertiary care hospital

  2018cites this paper
• Fungal peritonitis in peritoneal dialysis: a 34-year single centre evaluation

  2018cites this paper
• Viridans streptococcus peritonitis in peritoneal dialysis: clinical characteristics and comparison with concurrent polymicrobial infection

  2018cites this paper
• The new ISPD peritonitis guideline

  2018cites this paper
• Peritoneal dialysis-related peritonitis caused by Pseudomonas species: Insight from a post-millennial case series

  2018cites this paper
• ISPD Catheter-Related Infection Recommendations: 2017 Update

  2017cites this paper
• Short-Dwell Cycling Intraperitoneal Cefazolin Plus Ceftazidime in Peritoneal Dialysis Patients

  2017cites this paper
• Protective effect of a novel antibody against TLR2 on zymosan-induced acute peritonitis in NF-κB transgenic mice.

  2017cites this paper
• Effects of Erythropoiesis-stimulating Agents on Intestinal Flora in Peritoneal Fibrosis.

  2017cites this paper
• Intraperitoneal and Subsequent Intravenous Vancomycin: An Effective Treatment Option for Gram-Positive Peritonitis in Peritoneal Dialysis

  2017cites this paper
• Risk factors for encapsulating peritoneal sclerosis: Analysis of a 36‐year experience in a University Hospital

  2017cites this paper
• CATHETER-RELATED INFECTION RECOMMENDATIONS : 2017 UPDATE

  2017cites this paper
• Physicochemical Transformations of ZnO Nanoparticles Dispersed in Peritoneal Dialysis Fluid: Insights into Nano–Bio Interface Interactions

  2017cites this paper
• Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients.

  2017cites this paper
• Peritonitis before Peritoneal Dialysis Training: Analysis of Causative Organisms, Clinical Outcomes, Risk Factors, and Long-Term Consequences.

  2016cites this paper
• ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment

  2016cites this paper
• Complications of Peritoneal Dialysis

  2016cites this paper
• Peritoneal dialysis-related infections in patients on peritoneal dialysis and measures designed to prevent them

  2016cites this paper
• Newer antibiotics for the treatment of peritoneal dialysis-related peritonitis

  2016cites this paper
• Role of predictors and rapid diagnosis of fungal peritonitis in CAPD patients

  2016cites this paper
• Predictors of Residual Renal Function Decline in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis

  2015cites this paper
• Development of Acute Peritonitis after Gynecological Procedure in a Peritoneal Dialysis Patient

  2015cites this paper
• Peritoneal Dialysis Can Be an Option for Dominant Polycystic Kidney Disease: an Observational Study

  2015cites this paper
• Use of biogenic nanomaterials to improve the peritoneal dialysis technique: A Translational Research Perspective

  2015cites this paper
• Unusual CAPD Citrobacter freundii Peritonitis Complicated by a Fungal Infection, Identified by 16s Ribosomal RNA Gene Sequencing

  2015cites this paper
• Meropenem Plus Tobramycin Followed by Meropenem Plus Vancomycin for Treating Peritoneal Dialysis-Related Peritonitis---Single Center Experience-- -

  2015cites this paper
• Evidence-based medicine: An update on treatments for peritoneal dialysis-related peritonitis.

  2015cites this paper
• A Rare Case of Peritonitis: Streptococcus Salivarius

  2015cites this paper
• Utilidad de las tiras reactivas multistix 10 SG® en el diagnóstico de peritonitis en diálisis peritoneal

  2015cites this paper
• Elderly Peritoneal Dialysis Compared with Elderly Hemodialysis Patients and Younger Peritoneal Dialysis Patients: Competing Risk Analysis of a Korean Prospective Cohort Study

  2015cites this paper
• Viridans Streptococci in Peritoneal Dialysis Peritonitis: Clinical Courses and Long-Term Outcomes

  2015cites this paper
• Peritonitis in children with automated peritoneal dialysis.

  2015cites this paper
• Clarification of Trimethoprim/Sulfamethoxazole Dose in CAPD

  2015cites this paper
• Peritonitis due to Candida Guilliermondii in a Patient on Continuous Ambulatory Peritoneal Dialysis

  2015cites this paper
• Seasonal variations and influence of the weather on the appearance of peritoneal infection.

  2014cites this paper
• UF-1000i: validation of the body fluid mode for counting cells in body fluids

  2014cites this paper
• Fungal peritonitis in continuous ambulatory peritoneal dialysis: The impact of antifungal prophylaxis on patient and technique outcomes

  2014cites this paper
• Mycobacterium fortuitum peritonitis in peritoneal dialysis and its effects on the peritoneum.

  2014cites this paper
• Peritoneal dialysis-related peritonitis due to coagulase-negative Staphylococcus: a review of 115 cases in a Brazilian center.

  2014cites this paper
• Risk Factors for Encapsulating Peritoneal Sclerosis in Long‐Term Peritoneal Dialysis: A Retrospective Observational Study

  2014cites this paper
• Metabolite characterisation in peritoneal dialysis effluent using high‐resolution 1H and 1H–13C NMR spectroscopy

  2014cites this paper
• Peritoneal dialysis-related peritonitis: twenty-seven years of experience in a Colombian medical center.

  2014cites this paper
• Effect of N-acetylcysteine in the prevention of ototoxicity caused by vancomycin in the treatment of peritonitis in patients undergoing peritoneal dialysis

  2014cites this paper
• ispd guidelines/ReCOMMendA Ti Ons

  2014cites this paper
• Fungal peritonitis and cancer near the abdominal regions

  2014cites this paper
• AADNMR: A Simple Method for Rapid Identification of Bacterial/Mycobacterial Infections in Antibiotic Treated Peritoneal Dialysis Effluent Samples for Diagnosis of Infectious Peritonitis

  2014influential citation
• Escherichia coli Peritonitis in Peritoneal Dialysis: The Prevalence, Antibiotic Resistance and Clinical Outcomes in a South China Dialysis Center

  2014cites this paper
• Efficacy of antibiotic therapy for peritoneal dialysis-associated peritonitis: a proportional meta-analysis

  2014cites this paper
• Long-Term Clinical Outcomes of Peritoneal Dialysis Patients: 9-Year Experience of a Single Center from North India

  2014cites this paper
• Acinetobacter Peritoneal Dialysis Peritonitis: A Changing Landscape over Time

  2014cites this paper
• First Case of Continuous Ambulatory Peritoneal Dialysis-Related Peritonitis Caused by Cryptococcus arboriformis

  2014cites this paper
• Practical Considerations When Prescribing Icodextrin: A Narrative Review

  2014cites this paper
• Microbiological aspects of peritonitis in patients undergoing chronic peritoneal dialysis at the dialysis unit of Sri Jayawardenapura General Hospital.

  2014cites this paper
• Effect of N-acetylcysteine in the prevention of ototoxicity caused by vancomycin in the treatment of peritonitis in patients undergoing peritoneal dialysis

  2014cites this paper
• Outcomes of chronic dialysis in Korean children with respect to survival rates and causes of death

  2014cites this paper
• Peritoneal dialysis peritonitis by anaerobic pathogens: a retrospective case series

  2013cites this paper
• Update on the challenging role of biofilms in peritoneal dialysis

  2013cites this paper
• Long-Term Peritoneal Dialysis Experience: Quality Control Supports the use of Fluconazole to Prevent Fungal Peritonitis

  2013cites this paper
• Citrobacter Peritoneal Dialysis Peritonitis: Rare Occurrence with Poor Outcomes

  2013cites this paper
• Neutrophil gelatinase-associated lipocalin in peritoneal dialysis reflects status of peritoneum.

  2013cites this paper
• Primer episodio de infección peritoneal: descripción y factores pronósticos

  2013cites this paper
• Eosinophilic Peritonitis – A Clinical Decision

  2013cites this paper
• Rare anaerobic peritoneal dialysis peritonitis , fair outcomes : A case series

  2013cites this paper
• Peritoneal Dialysis Catheter Placement and Management

  2013cites this paper
• Peritoneal Dialysis: Initiation and Complications

  2013cites this paper
• First episodes of peritoneal infection: description and prognostic factors.

  2013cites this paper
• A comparative proteomics analysis of peritoneal dialysate before and after the occurrence of peritonitis episode by mass spectrometry.

  2013cites this paper
• STABILITY STUDY OF ANTIBIOTIC ( CEFOTAXIME ) IN PERITONEAL DIALYSIS SOLUTION WITH VALIDATION OF ANALYZING METHOD

  2013cites this paper
• Modelling competing risks in nephrology research: an example in peritoneal dialysis

  2013cites this paper
• Infectious complications in dialysis—epidemiology and outcomes

  2012cites this paper
• Pharmacokinetics of clindamycin in the plasma and dialysate after intraperitoneal administration of clindamycin phosphoester to patients on continuous ambulatory peritoneal dialysis: an open-label, prospective, single-dose, two-institution study.

  2012cites this paper
• Peritonitis and Exit-Site Infections

  2012cites this paper
• Cyclic Pseudoperitonitis Secondary to Endometriosis in a Peritoneal dialysis Patient

  2012cites this paper
• Morphological analysis of biofilm of peritoneal dialysis catheter in refractory peritonitis patient

  2012cites this paper
• Peritonitis in recent years: clinical findings and predictors of treatment response of 170 episodes at a single Brazilian center

  2012cites this paper
• The role of γδ T cells in peritoneal dialysis-associated bacterial infection

  2012cites this paper
• Peritoneal Dialysis-Related Fungal Peritonitis: Twenty-Year Experience of a Medical Center in Southern Taiwan

  2012cites this paper
• Use of aminoglycosides for peritoneal dialysis-associated peritonitis does not affect residual renal function.

  2012cites this paper
• Peritoneal Dialysis-Related Peritonitis Due to Staphylococcus aureus: A Single-Center Experience over 15 Years

  2012cites this paper
• Cyclic Pseudoperitonitis Secondary to Endometriosis in a Peritoneal Dialysis Patient

  2012cites this paper
• Dimitrios G. Oreopoulos--an appreciation.

  2012cites this paper